| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 0.480 | None | 1.000 | 7 | 0 | 1996 | 2014 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.450 | None | 1.000 | 5 | 0 | 1994 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.430 | None | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.962 | 154 | 8 | 1991 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 24 | 2 | 2008 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.400 | None | 0.818 | 10 | 0 | 2003 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.400 | None | 0.909 | 10 | 0 | 2000 | 2018 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2001 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2001 | 2014 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2001 | 2004 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.330 | None | 0.667 | 3 | 0 | 1996 | 2010 | ||||||||
|
KIAA1549 | 0.615 | 0.346 | 0.99 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2010 | 2014 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2013 | ||||||||
|
activin A receptor type 1 | 0.535 | 0.731 | 0.33 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2014 | 2014 | ||||||||
|
large tumor suppressor kinase 2 | 0.554 | 0.654 | 0.99 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
nuclear receptor coactivator 3 | 0.522 | 0.654 | 0.54 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2014 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
notch receptor 2 | 0.441 | 0.808 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2013 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2017 | ||||||||
|
large tumor suppressor kinase 1 | 0.563 | 0.731 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.220 | None | 1.000 | 2 | 0 | 1997 | 2017 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.200 | None | 0.959 | 119 | 3 | 2008 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.200 | None | 0.964 | 55 | 1 | 2009 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.200 | None | 1.000 | 39 | 0 | 1994 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.200 | None | 1.000 | 10 | 0 | 1991 | 2011 |